Abstract

PreScription: Compounded Drugs Often Become Manufactured Drugs

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2022 - Volume 26, Number 6

View All Articles in Issue

Page(s): 444

Download in electronic PDF format for $75

Abstract

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2022 Pg. 444	PreScription: Compounded Drugs Often Become Manufactured Drugs Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 4	PreScription: New Drug Approvals 2022 and Compounding Opportunities Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 292-293	Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 101-111	Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Author(s): Timko Robert J, Crooker Philip EM
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Sep/Oct 2013 Pg. 356	PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 387-398	Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Author(s): Ashe Krystina, Baskett Dustin
Jan/Feb 2003 Pg. 21-23	Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Author(s): Vail Jane
Jul/Aug 2002 Pg. 271-273	Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer Author(s): Kramer Mark A, Grilley Bambi J
Sep/Oct 2014 Pg. 379-380	Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Author(s): Blankenship Cynthia E
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
May/Jun 2013 Pg. 180	PreScription: Compounding for Drug Shortages Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 307-311	Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations Author(s): McElhiney Linda F
Mar/Apr 2011 Pg. 92	PreScription: Discontinued Drugs and Drug Shortages Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr